These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11049194)

  • 21. PET in radiotherapy planning: particularly exquisite test or pending and experimental tool?
    Gregoire V; Chiti A
    Radiother Oncol; 2010 Sep; 96(3):275-6. PubMed ID: 20708810
    [No Abstract]   [Full Text] [Related]  

  • 22. 4th international symposium on targeted radiotherapy and dosimetry (ISTARD): best ranked abstract publication.
    Chiesa C; Luster M; Lassmann M
    Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):485-6. PubMed ID: 23358399
    [No Abstract]   [Full Text] [Related]  

  • 23. Semi-automated radiotherapy treatment planning with a mathematical model to satisfy treatment goals.
    Powlis WD; Altschuler MD; Censor Y; Buhle EL
    Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):271-6. PubMed ID: 2912950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosimetry in nuclear medicine therapy.
    Chiesa C; Lassmann M
    Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):2-4. PubMed ID: 21386781
    [No Abstract]   [Full Text] [Related]  

  • 25. Standard effective doses for proliferative tumours.
    Jones LC; Metcalfe P; Hoban P; Fox C
    Phys Med Biol; 1999 Sep; 44(9):2127-42. PubMed ID: 10495109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The on-going quest for treatment precision and conformality in radiotherapy.
    Muren LP; Thwaites DI
    Radiother Oncol; 2013 Dec; 109(3):337-41. PubMed ID: 24315360
    [No Abstract]   [Full Text] [Related]  

  • 27. Nuclear medicine dosimetry: quantitative imaging and dose calculations.
    Glatting G; Lassmann M
    Z Med Phys; 2011 Dec; 21(4):246-7. PubMed ID: 21862300
    [No Abstract]   [Full Text] [Related]  

  • 28. From the magic bullet to an effective therapy: the peptide experience.
    Mansi L
    Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1393-8. PubMed ID: 15351914
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical use of PET-CT data for radiotherapy planning: what are we looking for?
    Chiti A; Kirienko M; Grégoire V
    Radiother Oncol; 2010 Sep; 96(3):277-9. PubMed ID: 20727607
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of the SUV values calculation and 4D PET integration in the radiotherapy treatment planning system.
    Jacob V; Astner ST; Bundschuh RA; Busch R; Souvatzoglou M; Wendl C; Kneschaurek P; Grosu AL
    Radiother Oncol; 2011 Mar; 98(3):323-9. PubMed ID: 21296443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recommendations on how to establish evidence from auto-segmentation software in radiotherapy.
    Valentini V; Boldrini L; Damiani A; Muren LP
    Radiother Oncol; 2014 Sep; 112(3):317-20. PubMed ID: 25315862
    [No Abstract]   [Full Text] [Related]  

  • 32. Multi-modality optimisation in radiotherapy treatment planning using composite objective values.
    Petersson K; Nilsson P; Engström P; Knöös T; Ceberg C
    Acta Oncol; 2015 Apr; 54(4):552-6. PubMed ID: 25178091
    [No Abstract]   [Full Text] [Related]  

  • 33. MMCTP: a radiotherapy research environment for Monte Carlo and patient-specific treatment planning.
    Alexander A; Deblois F; Stroian G; Al-Yahya K; Heath E; Seuntjens J
    Phys Med Biol; 2007 Jul; 52(13):N297-308. PubMed ID: 17664568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Point/Counterpoint. MRI/CT is the future of radiotherapy treatment planning.
    Glide-Hurst CK; Low DA; Orton CG
    Med Phys; 2014 Nov; 41(11):110601. PubMed ID: 25370613
    [No Abstract]   [Full Text] [Related]  

  • 35. Point/counterpoint. Respiratory gating for radiation therapy is not ready for prime time.
    Li XA; Keall PJ; Orton CG
    Med Phys; 2007 Mar; 34(3):867-70. PubMed ID: 17441231
    [No Abstract]   [Full Text] [Related]  

  • 36. Knowledge-based planning for stereotactic radiotherapy of peripheral early-stage lung cancer.
    Delaney AR; Dahele M; Tol JP; Slotman BJ; Verbakel WF
    Acta Oncol; 2017 Mar; 56(3):490-495. PubMed ID: 28067088
    [No Abstract]   [Full Text] [Related]  

  • 37. Rethink radiotherapy - BIGART 2017.
    Grau C; Høyer M; Poulsen PR; Muren LP; Korreman SS; Tanderup K; Lindegaard JC; Alsner J; Overgaard J
    Acta Oncol; 2017 Nov; 56(11):1341-1352. PubMed ID: 29148908
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of molecular imaging in precision radiation therapy for target definition, treatment planning optimisation and quality control.
    Lucignani G; Jereczek-Fossa BA; Orecchia R
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1059-63. PubMed ID: 15057490
    [No Abstract]   [Full Text] [Related]  

  • 39. Functional image-guided intensity modulated radiation therapy: integration of the tumour microenvironment in treatment planning.
    Grégoire V; Haustermans K
    Eur J Cancer; 2009 Sep; 45 Suppl 1():459-60. PubMed ID: 19775671
    [No Abstract]   [Full Text] [Related]  

  • 40. The importance of dosimetry in nuclear medicine therapy practice.
    Bisi G
    Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):1. PubMed ID: 21386780
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.